2012
DOI: 10.1016/j.apmr.2012.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Subacromial Corticosteroid Injection on Poststroke Hemiplegic Shoulder Pain: A Randomized, Triple-Blind, Placebo-Controlled Trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
28
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 36 publications
(31 citation statements)
references
References 37 publications
3
28
0
Order By: Relevance
“…Snels and colleagues 137 showed no significant effect on pain reduction after glenohumeral injection. In contrast, Rah and others 138 showed a significant reduction in pain after corticosteroid injection compared with placebo. In the latter study, Rah et al selected only patients with shoulder joint pathology that was verified by ultrasonography.…”
Section: Assessment Prevention and Treatment Of Hemiplegic Shouldermentioning
confidence: 91%
“…Snels and colleagues 137 showed no significant effect on pain reduction after glenohumeral injection. In contrast, Rah and others 138 showed a significant reduction in pain after corticosteroid injection compared with placebo. In the latter study, Rah et al selected only patients with shoulder joint pathology that was verified by ultrasonography.…”
Section: Assessment Prevention and Treatment Of Hemiplegic Shouldermentioning
confidence: 91%
“…It has been contended that IACI, if given at an early (eg, freezing) stage, may possibly minimize the morbidity of the disorder. Early treatment with IACI may provide a chemical ablation PM R 10 (2018) [19][20][21][22][23][24][25][26][27] www.pmrjournal.org of the synovitis that can help prevent the development of the fibrosis and shorten the natural history of the disease [2,4,9,10]. However, not enough studies exist to prove the effectiveness of early injection.…”
Section: Introductionmentioning
confidence: 99%
“…They were randomly assigned to receive ultrasound-guided subacromial injection with triamcinolone (treatment group, n = 29) or lidocaine (placebo group, n = 29). After 8-week follow-up from the single injection, subjects receiving subacromial corticosteroid injection showed improved pain, disability, and active range of motion, and the duration of its efficacy continued up to 8 weeks (Rah et al, 2012). Yasar et al (2011) performed an RCT including 26 patients more than 8 months after stroke.…”
Section: Pharmacologic Therapiesmentioning
confidence: 98%